Navigation Links
John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting
Date:5/29/2012

Hackensack, New Jersey (May 29, 2012) Physicians and researchers at John Theurer Cancer Center at HackensackUMC, one of the nation's top 50 cancer centers, will present the latest findings in blood-cancer research at the 2012 American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 1-5. Their involvement in these studies is part of John Theurer Cancer Center's continued focus to bolster its research program.

"We are proud to make a contribution to this premiere oncology conference, but we also know there is a lot of work ahead, " said Andre Goy, M.D., M.S., chairman and director and chief of lymphoma, John Theurer Cancer Center. "We are placing significant resources towards further advancing cancer research, such as the recent expansion of our Phase 1 Unit to spearhead early drug development."

Blood cancer research highlights include studies in multiple myeloma and leukemia, including two oral presentations evaluating combination therapies for multiple myeloma patients, results of a multicenter study for newly diagnosed chronic myeloma leukemia, findings of a multi-center phase II study evaluating dose regimens in older patients with MDS refractory, and an analysis of a salvage therapy for first relapse acute myeloid leukemia.

John Theurer Cancer Center oral and presentation highlights at the ASCO annual meeting include:

  • 6509 - Nilotinib versus imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up, Stuart Goldberg, MD et all. Poster Session: June 1, 2012 1:00pm-5:00pm
  • 6520 - A randomized phase II study of sapacitabine in MDS refractory to hypomethylating agents, Stuart Goldberg, MD et. All. Poster Session: June 1, 2012 1:00-5:00pm
  • 6525 - Initial salvage therapy in first relapse AML: A phase IIb study of CPX-351 versus investigator's choiceA subset analysis by prognostic group, Stuart Goldberg, MD et all. Poster Session: June 1, 201
    '/>"/>

Contact: Amy Leahing
aleahing@p4strategy.com
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. John Theurer Cancer Center BMT researchers highlight the importance of social support
2. John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
3. National experts from the John Theurer Cancer Center will present 31 studies at the 2011 ASH Meeting
4. Breast cancer treatment resistance linked to signaling pathway
5. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
6. The dietary supplement genistein can undermine breast cancer treatment
7. Saliva proteins could help detection of oral cancer
8. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
9. Breakthrough optical technology to assess colon cancer risk, accuracy
10. Breast cancer cells recycle to escape death by hormonal therapy
11. Nanodiamond drug device could transform cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2015)... July 13, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced sampling of ClearPad ® ... driver integration (TDDI) product targeting smartphones and tablets. ... combine Synaptics , best-in-class touch controller IP ... technology developed in the company,s Japan Design Center. ...
(Date:7/9/2015)... Calif. , July 9, 2015 /PRNewswire/ ... leading developer of human interface solutions, today ... the industry,s first fully hardware encapsulated fingerprint ... secure authentication technology is literally off the ... and biometric matching within the fingerprint sensor ...
(Date:7/7/2015)... , June 30, 2015 ... announced the addition of the "Capacitive Fingerprint ... To this date, fingerprint sensing technology ... and fingerprint sensors are well developed. This patent ... technology. The domain of capacitive fingerprint ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... good enough, a new study published in the December 2008 ... may want to think again. In the report, researchers from ... having high levels of good cholesterol (HDL) and low levels ... they show that the good cholesterol has varying degrees of ...
... ubiquitous pollutant that has a potent effect on gene ... in the December issue of BioScience . The ... a wood and textile preservative, and as a pesticide ... , Tributyltin affects sensitive receptors in the cells of ...
... from across Europe are embarking on new research to develop ... 10 million EU citizens and there is no cure," says ... lead partner in the Food Allergy Specific Therapy (FAST) research ... the foods to which they are allergic. The threat of ...
Cached Biology News:Persistent pollutant may promote obesity 2Scientists developing food allergy treatment 2
(Date:7/27/2015)... EDMONTON , July 27, 2015 /PRNewswire/ - Quest ... pharmaceutical company developing and commercializing products for the treatment ... Quest announces that it has closed a $1,000,000 ... private placement of 16,666,667 units of the Company at ... comprised of one common share and one common share ...
(Date:7/27/2015)... ... 2015 , ... Brady (NYSE:BRC), a global leader ... Ways to GHS Labels . This video provides useful information on how to ... effectively labeling chemical containers. , “With the fourth and final deadline for HazCom/GHS ...
(Date:7/27/2015)... ... July 27, 2015 , ... BlueInGreen® announced the addition ... will bring the world’s most efficient gas dissolution technology to all of Florida, ... both the industrial and municipal markets. With offices located in Sarasota, Sebring and ...
(Date:7/27/2015)... , July 27, 2015 Junto Health, ... startups share information and develop new technology solutions, today ... Policy Group (SPG), a leader in health care policy ... now engage in a collaborative innovation process while, at ... latest trends in public policy, health care finance and ...
Breaking Biology Technology:Quest PharmaTech Closes $1,000,000 Private Placement 2Brady Releases “3 Roads to GHS Labels” Video 2BlueInGreen Brings Water Treatment Technology to Florida 2Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4
... Oct. 31, 2011 Reportlinker.com announces ... is available in its catalogue: ... Pipeline Analysis, Opportunity Assessment and Market ... http://www.reportlinker.com/p0317992/Spinal-Implants---Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices Spinal ...
... 31, 2011 NuMe Health LLC, a biotechnology ... disease and improve disease status by modifying  the ... today announced the formation of its scientific advisory ... and industry in the fields of nutrition, diabetes, ...
... 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE ... revolutionary bone graft material and antimicrobial coatings for medical applications, ... "...One More Day." Bacterin and one of ... the Rose Parade and will be recognized as one of ...
Cached Biology Technology:Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 4Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 5Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 6Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 7Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 8Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 9Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 10NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product 2NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product 3NuMe Health Advances its Cobiotics™ Technology With Addition of Scientific Advisory Board and Filing of Patent Application for First Product 4Bacterin Sponsors the 2012 Donate Life Rose Parade Float in Recognition of Donor Families 2Bacterin Sponsors the 2012 Donate Life Rose Parade Float in Recognition of Donor Families 3
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
... siRNA Custom Synthesis Service provides ... RNA to knockdown any gene. ... RNA base pairs with terminal ... or other lengths of your ...
Alexa Fluor 647 anti-mouse Qa-2...
...
Biology Products: